Opus Genetics IRD
NASDAQ IRD
$4.39 +0.16 (+3.90%)
As of: Nov 11, 2026 · 1:20 PM EST

Opus Genetics (IRD) Price to Earnings (2009 - 2023)

Updated

Opus Genetics' (IRD) Price to Earnings came in at 2.63 for Q3 2023, down 46.0% from the prior quarter.

Analysis

Opus Genetics (IRD) Price to Earnings (2009 - 2023) Analysis & Trends

For FY2022, Opus Genetics' Price to Earnings stood at 4.12.

  • According to Business Quant data, Price to Earnings for the three prior quarters was 4.88 (Q2 2023), 4.20 (Q1 2023) and 4.12 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Opus Genetics 405.23 Mn 122.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 2.63
Jun 30, 2023 4.88
Mar 31, 2023 4.20
Dec 31, 2022 4.12
Jun 30, 2010 0.59
Mar 31, 2010 0.64
Dec 31, 2009 0.26
Sep 30, 2009 257.05
API Access

Opus Genetics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=IRD&period=max&api_key=YOUR_API_KEY